1) Moses AW, Slater C, Fearon KC, et al : Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90 : 996─1002, 2004
2) Bachmann J, Heiligensetzer M, Martignoni ME, et al : Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12 : 1193─1201, 2008
3) Dewys WD, et al : Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69 : 491─497, 1980
4) Fearon KC, Voss AC, Hustead DS : Definition of cancer cachexia : effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83 : 1345─1350, 2006
5) Spiro A, Baldwin C, Andreyev HJ, et al : The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 95 : 431─434, 2006
6) Definition and classification of cancer cachexia : an international consensus. : Fearon K, Strasser F, Baracos VE, et al : Lancet Oncol 12 : 489─495, 2011
7) 東口髙志 : 実践!がん患者の栄養管理と疼痛管理.癌の臨床53 : 199─209,2007
8) 東口髙志,森居 純,伊藤彰博,他 : 全身症状に対する緩和ケア.外科治療96 : 934─941,2007
9) 東口髙志,伊藤彰博,飯田俊雄,他 : 末期癌患者の輸液療法.日医師会誌132 : 61─64,2004
10) Doyle D, Hanks G, Cherny NI, Calman K : Oxford Textbook of Palliative Medicine(2004)Oxford : Oxford University Press